Healthtech Series C Investors & VC Firms
771 firms in this list, with a median first check of $1M. 164 of them lead rounds. Generated from verified public data and updated continuously.
Impulsora de Innovacion Mexico
Mexico CityPre-Seed–Growth$1M
Jebsen Capital
Hong KongSeries A–Late Stage
Laval Innov
LavalPre-Seed–Late Stage
MagogTechnopole
MagogPre-Seed–Late Stage
NIPPON EXPRESS HOLDINGS
Seed–Growth
North Forge Technology Exchange
WinnipegPre-Seed–Late Stage
Northwestern Ontario Innovation Centre
Thunder BayPre-Seed–Late Stage
RKCA
CincinnatiPre-Seed–Late Stage
SCP
Hong KongSeed–Late Stage
Sheares Healthcare Group
SingaporeSeed–Late Stage
Technology Innovation Agency
PretoriaPre-Seed–Growth
ZEISS Ventures
OberkochenSeed–Growth
Mitsui Sumitomo Insurance Capital
TokyoPre-Seed–Late Stage$1.1M – $198M
1 person
Alibaba Entrepreneurs Fund
Hong KongSeed–Late Stage$1.2M – $150M
2 people
Redpoint Ace Ventures
ShanghaiSeed–Late Stage
5 people
Baidu Ventures
BeijingSeed–Growth$1.4M – $145M
2 people
GBS Venture Partners Ltd.
MelbourneSeed–Growth$165K – $7.9M
2 people
Hiventures
BudapestSeed–Late Stage$43.2K – $43.2M
2 people
Longbow Capital LLP
NorwichSeries C–Late Stage$1.3M – $12.7M
2 people
Nissay Capital
TokyoPre-Seed–Late Stage$610K – $71M
1 person
Annox Capital
BirminghamSeed–Late Stage$100K – $30M
1 person
Cutlass Capital, L.L.C.
BostonSeed–Late Stage$3M – $7M
1 person
FFG Venture Business Partners
FukuokaPre-Seed–Late Stage$1M – $50M
1 person
Gentree Fund
SingaporeSeed–Series C$1M – $60M
1 person
Related lists
Healthtech Investors & VC Firms (3208)Series C Investors & VC Firms (2751)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Healthtech Investors & VC Firms in United States (1616)Healthtech Pre-Seed Investors & VC Firms (1328)Healthtech Series B Investors & VC Firms (1216)Healthtech Growth Investors & VC Firms (1213)Series C Investors & VC Firms in United States (946)Series C Investors & VC Firms in Global (896)
Data sourced from public filings and firms' own websites — see our methodology.